Source: BIOSPACE

Cadence Pharmaceuticals: Cadence Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Cadence Pharmaceuticals's Competitors | Cadence Pharmaceuticals's News | Cadence Pharmaceuticals's Financials
Stay up-to-date with the latest news on Cadence Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Theodore Schroeder's photo - President & CEO of Cadence Pharmaceuticals

President & CEO

Theodore Schroeder

CEO Approval Rating

91/100

Read more
Stay up-to-date with the latest news on Cadence Pharmaceuticals